Orchid Pharma Limited
NSE:ORCHPHARMA.NS
1445.25 (INR) • At close November 1, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
| 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q2 | 2017 Q2 | 2015 Q1 | 2013 Q2 | 2012 Q4 | 2012 Q2 | 2011 Q4 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 2,444.061 | 2,171.021 | 2,205.91 | 1,987.553 | 1,829.198 | 2,099.008 | 1,597.603 | 1,652.496 | 1,309.877 | 1,781.323 | 1,613.765 | 1,277.357 | 923.129 | 1,195.597 | 1,027.84 | 1,085.531 | 1,191.636 | 1,115.226 | 1,294.633 | 1,316.346 | 1,354.199 | 1,424.798 | 2,093.415 | 2,563.329 | 3,772.5 | 2,681.567 | 3,305.481 | 4,519.175 |
| Cost of Revenue
| 1,806.993 | 1,541.091 | 1,219.389 | 1,223.301 | 1,120.677 | 1,189.022 | 956.005 | 1,003.195 | 697.985 | 1,147.047 | 924.296 | 713.129 | 478.378 | 897.845 | 596.239 | 394.788 | 511.067 | 892.901 | 561.635 | 559.467 | 657.642 | 596.877 | 1,132.173 | 1,278.674 | 1,833.821 | 1,354.389 | 1,570.826 | 2,075.366 |
| Gross Profit
| 637.068 | 629.93 | 986.521 | 764.252 | 708.521 | 909.986 | 641.598 | 649.301 | 611.892 | 634.276 | 689.469 | 564.228 | 444.751 | 297.752 | 431.601 | 690.743 | 680.569 | 222.325 | 732.998 | 756.879 | 696.557 | 827.921 | 961.242 | 1,284.655 | 1,938.679 | 1,327.178 | 1,734.655 | 2,443.809 |
| Gross Profit Ratio
| 0.261 | 0.29 | 0.447 | 0.385 | 0.387 | 0.434 | 0.402 | 0.393 | 0.467 | 0.356 | 0.427 | 0.442 | 0.482 | 0.249 | 0.42 | 0.636 | 0.571 | 0.199 | 0.566 | 0.575 | 0.514 | 0.581 | 0.459 | 0.501 | 0.514 | 0.495 | 0.525 | 0.541 |
| Reseach & Development Expenses
| 0 | 70.937 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 66.263 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 396.588 | 424.946 | 441.216 | 355.521 | 162.206 | 349.498 | 338.237 | 293.794 | 341.559 | 339.848 | 373.02 | 285.283 | 297.712 | 139.72 | 192.66 | 197.625 | 182.659 | 210.343 | 225.747 | 211.122 | 216.208 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Expenses
| 75.707 | -294.245 | -365.06 | 83.555 | 18.857 | -332.211 | -248.927 | 58.396 | 29.312 | -67.665 | 23.659 | 17.668 | 31.233 | -34.583 | 17.365 | 9.316 | 12.708 | -185.655 | 70.156 | 66.227 | 51.521 | 62.804 | 47.17 | 0 | 2,446.368 | 1,573.769 | 0.131 | 0.029 |
| Operating Expenses
| 396.588 | 424.946 | 284.098 | 609.223 | 564.173 | 235.734 | 248.584 | 648.714 | 703.693 | 604.117 | 751.006 | 651.842 | 650.177 | 231.854 | 770.878 | 810.913 | 784.047 | 463.02 | 1,047.219 | 1,083.01 | 1,132.542 | 1,089.788 | 1,059.953 | 1,058.134 | 2,446.368 | 1,573.769 | 1,735.773 | 1,952.885 |
| Operating Income
| 240.48 | 204.984 | 337.363 | 238.284 | 144.348 | 342.041 | 144.087 | 58.983 | -91.801 | 30.121 | -61.537 | -87.614 | -37.878 | 64.844 | -321.912 | -110.854 | -321.912 | -381.665 | -314.221 | -259.904 | -244.065 | -163.547 | -51.543 | -603.142 | -507.689 | -246.591 | -0.987 | 490.924 |
| Operating Income Ratio
| 0.098 | 0.094 | 0.153 | 0.12 | 0.079 | 0.163 | 0.09 | 0.036 | -0.07 | 0.017 | -0.038 | -0.069 | -0.041 | 0.054 | -0.313 | -0.102 | -0.27 | -0.342 | -0.243 | -0.197 | -0.18 | -0.115 | -0.025 | -0.235 | -0.135 | -0.092 | -0 | 0.109 |
| Total Other Income Expenses Net
| 40.723 | 98.843 | -35.438 | -38.046 | -50.3 | 317.266 | -76.803 | -92.212 | -49.092 | -41.561 | -44.152 | -81.265 | -67.811 | -99.296 | -125.334 | -133.314 | -125.334 | -6.928 | 37.294 | -0.913 | -32.862 | -67.787 | -754.51 | 0 | -1,355.781 | -985.571 | -302.507 | -610.699 |
| Income Before Tax
| 281.203 | 303.827 | 301.925 | 200.238 | 107.751 | 659.307 | 67.284 | -33.229 | -140.893 | -11.44 | -105.689 | -168.879 | -282.979 | -34.452 | -447.246 | -244.168 | -226.623 | -388.593 | -276.927 | -260.817 | -384.464 | -231.334 | -806.053 | -603.142 | -1,863.47 | -1,168.198 | -303.494 | -119.775 |
| Income Before Tax Ratio
| 0.115 | 0.14 | 0.137 | 0.101 | 0.059 | 0.314 | 0.042 | -0.02 | -0.108 | -0.006 | -0.065 | -0.132 | -0.307 | -0.029 | -0.435 | -0.225 | -0.19 | -0.348 | -0.214 | -0.198 | -0.284 | -0.162 | -0.385 | -0.235 | -0.494 | -0.436 | -0.092 | -0.027 |
| Income Tax Expense
| -1.541 | -31.191 | 7.612 | 2.201 | 18.857 | 67.911 | -8.585 | 20.719 | 38.553 | 57.45 | 56.602 | -645.232 | 32.943 | 193.252 | 0 | 133.314 | 125.334 | -0.882 | 70.156 | 0.913 | 32.862 | -0.063 | -102.65 | -127.52 | 140.002 | 154.486 | -104.033 | -325.287 |
| Net Income
| 293.506 | 335.267 | 294.313 | 198.037 | 94.048 | 591.396 | 75.869 | -53.948 | -150.134 | -65.864 | -138.632 | 494.021 | -309.037 | -247.263 | -447.246 | -244.168 | -226.623 | -388.593 | -276.927 | -260.817 | -384.464 | -231.251 | -703.403 | -475.622 | -2,003.472 | -1,322.684 | -199.461 | 205.512 |
| Net Income Ratio
| 0.12 | 0.154 | 0.133 | 0.1 | 0.051 | 0.282 | 0.047 | -0.033 | -0.115 | -0.037 | -0.086 | 0.387 | -0.335 | -0.207 | -0.435 | -0.225 | -0.19 | -0.348 | -0.214 | -0.198 | -0.284 | -0.162 | -0.336 | -0.186 | -0.531 | -0.493 | -0.06 | 0.045 |
| EPS
| 5.79 | 6.81 | 5.8 | 3.9 | 1.85 | 14.49 | 1.86 | -1.32 | -3.68 | -1.61 | -3.4 | 12.1 | -7.57 | -6.06 | -10.96 | -5.98 | -5.55 | -9.52 | -6.78 | -2.93 | -4.32 | -2.6 | -7.91 | -5.58 | -28.44 | -18.77 | -2.83 | 2.92 |
| EPS Diluted
| 5.79 | 6.81 | 5.8 | 3.9 | 1.85 | 14.49 | 1.86 | -1.32 | -3.68 | -1.6 | -3.4 | 12.1 | -7.57 | -6.06 | -10.96 | -5.98 | -5.55 | -9.52 | -6.78 | -2.93 | -4.32 | -2.6 | -7.91 | -5.58 | -28.44 | -18.77 | -2.83 | 2.92 |
| EBITDA
| 324.919 | 289.184 | 430.05 | 316.693 | 240.28 | 414.162 | 225.9 | 236.625 | 153.803 | 299.312 | 164.371 | 130.722 | 26.933 | 268.118 | -31.984 | 188.63 | 205.708 | -69.673 | 72.419 | 57.131 | -70.764 | 165.961 | 284.842 | 594.297 | -60.059 | 203.714 | 394.522 | 917.934 |
| EBITDA Ratio
| 0.133 | 0.133 | 0.195 | 0.159 | 0.131 | 0.197 | 0.141 | 0.143 | 0.117 | 0.168 | 0.102 | 0.102 | 0.029 | 0.224 | -0.031 | 0.174 | 0.173 | -0.062 | 0.056 | 0.043 | -0.052 | 0.116 | 0.136 | 0.232 | -0.016 | 0.076 | 0.119 | 0.203 |